Cargando…
Multiple drugs: Mild cholestasis, hepatotoxicity and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972747/ http://dx.doi.org/10.1007/s40278-022-12586-2 |
Ejemplares similares
-
Hydroxychloroquine: Hepatotoxicity following off-label treatment: case report
Publicado: (2020) -
Multiple drugs: Protracted severe COVID-19 pneumonia, hepatotoxicity and lack of efficacy following off label use: case report
Publicado: (2022) -
Methylprednisolone/tocilizumab: Hepatotoxicity, cytomegalovirus reactivation and off label use: 2 case reports
Publicado: (2021) -
Multiple drugs: Drugs ineffective and off-label use: case report
Publicado: (2022) -
Multiple drugs: No improvement and off label use: case report
Publicado: (2022)